foxo4-dri human study FOX04-DRI (10mg) – Nordsci The disordered p53 transactivation domain
The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications FOXO4 DRI alleviates age related testosterone secretion insufficiency by targeting senescent Leydig cells in aged mice Aging FOXO4 DRI 10mg PeptideX Research FOXO4 DRI Peptide for Cellular Senescence and Anti Aging Research
Pay in 4 interest-free payments of $5.18 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22


